In the whole process of vitiligo disease, cellular immune function regulation is mainly acted upon by Th1 and Th17 cells, and interleukin-17A (IL-17A) is significantly increased in the cellular expression level of patients’ serum when Th1 and Th17 cells’ levels significantly increase in the peripheral blood (96). The gene discussed is IL17A; the disease is vitiligo.